ClinicalTrials.gov
public full text
Public Domain
Vascutek Anaconda™ Abdominal Aortic Aneurysm (AAA) Post-Market Surveillance Registry
The purpose of this observational Post-Market Surveillance Registry is to gather post-market data on the performance of the CE marked Vascutek Anaconda™ Stent Graft System for the repair of Abdominal Aortic Aneurysms (AAA). The Study population consists of patients suitable for endovascular repair of AAA. Patients will be followed at 1, 3, 6, 12, 18, 24, 36, 48 and 60 months post-implantation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Endurant Evo International Clinical Trial#883825
- Endurant Evo US Clinical Trial#1095795
- Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm#833519
- E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms#874929
- Safety and Performance of Altura Endograft in Abdominal Aortic Aneurysm (AAA) Endovascular Repair#866230
Record · ID 1009165
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive